Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)

Abstract Since the early 1970s, the World Health Organization and the International Federation of Gynecology and Obstetrics have classified borderline ovarian tumors as an independent group of ovarian epithelial tumors. A consensus statement of the Gynecologic Cancer Intergroup is reported.

[1]  T. Fehm,et al.  Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. , 2013, European journal of cancer.

[2]  P. Morice,et al.  Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. , 2013, Human reproduction update.

[3]  Jeong-Won Lee,et al.  Histologic distribution of borderline ovarian tumors worldwide: a systematic review , 2013, Journal of gynecologic oncology.

[4]  E. Darai,et al.  Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. , 2012, The Lancet. Oncology.

[5]  A. Bois,et al.  Borderline-Tumoren des Ovars – eine systematische Übersicht , 2009 .

[6]  A. Sood,et al.  Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. , 2009, Gynecologic oncology.

[7]  P. Morice,et al.  Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. , 2009, The oncologist.

[8]  W. Kuehn,et al.  Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany , 2009, British Journal of Cancer.

[9]  L. Holmberg,et al.  Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer , 2008, International journal of cancer.

[10]  E. Oliva,et al.  A practical approach to intraoperative consultation in gynecological pathology. , 2008, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  P. Neven,et al.  Management of borderline ovarian neoplasms. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Staff,et al.  Surgery of borderline tumors of the ovary: retrospective comparison of short‐term outcome after laparoscopy or laparotomy , 2007, Acta obstetricia et gynecologica Scandinavica.

[13]  N. Yaegashi,et al.  Clinical outcome and risk factors for recurrence in borderline ovarian tumours , 2006, British Journal of Cancer.

[14]  G. Acs.  Serous and mucinous borderline (low malignant potential) tumors of the ovary. , 2005, American journal of clinical pathology.

[15]  J. McKenney,et al.  Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors): Outcome-Based Study of 276 Patients With Long-Term (≥5-Year) Follow-Up , 2005, The American journal of surgical pathology.

[16]  Jalid Sehouli,et al.  Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential , 2005, Oncogene.

[17]  W. R. Hart.  Borderline epithelial tumors of the ovary , 2005, Modern Pathology.

[18]  D. Mutch,et al.  Epithelial Ovarian Tumors of Low Malignant Potential: The Role of Microinvasion , 2002, Obstetrics and gynecology.

[19]  M. Sherman,et al.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. , 1996, The American journal of surgical pathology.

[20]  M. Weinstock,et al.  Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. , 1989, Cancer.

[21]  Peter Devilee,et al.  Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .